Clinical Trials
25 trialsNCT07124000 2026-06-01
DP-04
AstraZeneca
Recruiting
NCT06885424 2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
NCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT07318051 2026-01-15
SCORE
Natera, Inc.
Recruiting
NCT03702309 2025-11-26
LIBERATE
University Health Network, Toronto
Recruiting
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT04053114 2025-08-29
MOLTHYSO
Institut Bergonié
Withdrawn
NCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT05697198 2025-03-06
PREFER
Labcorp Corporation of America Holdings, Inc
Completed
NCT05403177 2025-02-03
MOHCCN-O
University Health Network, Toronto
Recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT06583395 2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
NCT05099978 2024-09-04
A-TRAIN
National Cancer Center, Japan
Unknown
NCT06363123 2024-04-15
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Unknown
NCT00342446 2024-01-11
A Follow-up Study of Women Evaluated and Treated for Infertility
National Institutes of Health Clinical Center (CC)
Completed
NCT05685524 2023-01-17
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Unknown
NCT04334239 2022-08-23
WiZen
Technische Universität Dresden
Completed
NCT04545632 2022-07-27
DETECT
Boryung Pharmaceutical Co., Ltd
Completed
NCT04066335 2019-12-18
Study to Evaluate the Safety of Nanoxel M Inj.
Samyang Biopharmaceuticals Corporation
Unknown
NCT02900248 2019-04-02
N1
CureOne
Terminated
NCT00003569 2013-01-31
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
Roswell Park Cancer Institute
Completed
NCT01096381 2012-02-27
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Vanderbilt-Ingram Cancer Center
Terminated